Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Hypermutation In Pancreatic Cancer.

Authors:
Jeremy L Humphris Ann-Marie Patch Katia Nones Peter J Bailey Amber L Johns Skye McKay David K Chang David K Miller Marina Pajic Karin S Kassahn Michael C J Quinn Timothy J C Bruxner Angelika N Christ Ivon Harliwong Senel Idrisoglu Suzanne Manning Craig Nourse Ehsan Nourbakhsh Andrew Stone Peter J Wilson Matthew Anderson J Lynn Fink Oliver Holmes Stephen Kazakoff Conrad Leonard Felicity Newell Nick Waddell Scott Wood Ronald S Mead Qinying Xu

Gastroenterology 2017 01 15;152(1):68-74.e2. Epub 2016 Nov 15.

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.

Pancreatic cancer is molecularly diverse, with few effective therapies. Increased mutation burden and defective DNA repair are associated with response to immune checkpoint inhibitors in several other cancer types. We interrogated 385 pancreatic cancer genomes to define hypermutation and its causes. Mutational signatures inferring defects in DNA repair were enriched in those with the highest mutation burdens. Mismatch repair deficiency was identified in 1% of tumors harboring different mechanisms of somatic inactivation of MLH1 and MSH2. Defining mutation load in individual pancreatic cancers and the optimal assay for patient selection may inform clinical trial design for immunotherapy in pancreatic cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2016.09.060DOI Listing
January 2017

Publication Analysis

Top Keywords

pancreatic cancer
16
dna repair
8
cancer
5
immunotherapy pancreatic
4
highest mutation
4
identified tumors
4
deficiency identified
4
repair deficiency
4
mismatch repair
4
burdens mismatch
4
mutation burdens
4
repair enriched
4
enriched highest
4
harboring mechanisms
4
hypermutation pancreatic
4
inferring defects
4
signatures inferring
4
mutational signatures
4
hypermutation mutational
4
define hypermutation
4

Keyword Occurance

Similar Publications

Long noncoding RNAs (lncRNAs) in pancreatic cancer progression.

Authors:
Milad Ashrafizadeh Navid Rabiee Alan Prem Kumar Gautam Sethi Ali Zarrabi Yuzhuo Wang

Drug Discov Today 2022 May 16. Epub 2022 May 16.

Department of Urological Sciences, Vancouver, BC, V6H3Z6, Canada; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, V6H3Z6, Canada. Electronic address:

Long noncoding RNAs (lncRNAs) are RNA molecules involved in gene regulation at transcriptional, post-transcriptional, and epigenetic levels. lncRNAs participate in regulating apoptosis and autophagy in pancreatic cancer (PCa) and can promote and/or decrease the proliferation rate of tumor cells. The metastasis of PCa cells is tightly regulated by lncRNAs and they can affect the mechanism of epithelial-mesenchymal transition (EMT) to modulate metastasis. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada.

Authors:
Braulio A Marfil-Garza Sharleen Imes Kevin Verhoeff Joshua Hefler Anna Lam Khaled Dajani Blaire Anderson Doug O'Gorman Tatsuya Kin David Bigam Peter A Senior A M James Shapiro

Lancet Diabetes Endocrinol 2022 May 16. Epub 2022 May 16.

Department of Surgery, University of Alberta, Edmonton, AB, Canada; Clinical Islet Transplant Program, University of Alberta, Edmonton, AB, Canada; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada. Electronic address:

Background: Islet transplantation offers an effective treatment for selected people with type 1 diabetes and intractable hypoglycaemia. Long-term experience, however, remains limited. We report outcomes from a single-centre cohort up to 20 years after islet transplantation. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.

Authors:
Kazuhide Matsumoto Nao Fujimori Yoshitaka Hata Yosuke Minoda Masatoshi Murakami Katsuhito Teramatsu Yu Takamatsu Ayumu Takeno Takamasa Oono Eikichi Ihara Kohei Nakata Masafumi Nakamura Takeo Yamamoto Yutaka Koga Yoshinao Oda Tetsuhide Ito Yoshihiro Ogawa

Dig Dis 2022 May 19. Epub 2022 May 19.

Background: Neuroendocrine neoplasms of the ampulla of Vater (ampullary NEN) have features of both gastrointestinal and pancreato-biliary (PB) NEN. However, the limited number of studies examining ampullary NEN makes it difficult to clarify their unique characteristics. This study aimed to elucidate the clinical characteristics of ampullary NEN. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

IPO7 promotes pancreatic cancer progression via regulating ERBB pathway.

Authors:
Ming Li Dongqiang Xu Yijun Zhan Shiyun Tan

Clinics (Sao Paulo) 2022 May 16;77:100044. Epub 2022 May 16.

Department of Gastroenterology, Renmin Hospital of Wuhan University, Hubei Province, China.

Background: Importin 7 (IPO7) belongs to the Importin β family and is implicated in the progression of diverse human malignancies. This work is performed to probe the role of IPO7 in pancreatic cancer development and its potential downstream mechanisms.

Methods: IPO7 expression in PC and paracancerous tissues were measured using Immunohistochemistry (IHC) staining and qRT-PCR. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Clinical outcomes of patients with pancreatic tumors discussed in Tumor Board.

Authors:
Juliana Ribeiro Silva Rachel Simões Pimenta Riechelmann Bárbara Alana Vizzacchi Patricia Molina Victor Hugo Fonseca DE Jesus Felipe Jose Fernandez Coimbra Fulvio Aparecido Santos Alves Thamires DE Brito Camargo Gabriela Aguiar Vicente Dennys Ribeiro Dos Santos Victor Piana DE Andrade Genival Barbosa DE Carvalho

Rev Col Bras Cir 2022 27;49:e20223150. Epub 2022 Apr 27.

- AC Camargo Cancer Center - São Paulo - SP - Brasil.

Objective: the recommendations of the decisions made by the Tumor Board (TB) should be followed to identify barriers that may interfere with the execution of the previously decided, best care for the patient. The aim of this study is to assess whether the TB conduct decision was performed in patients with pancreatic tumors, their life status 90 days after the TB decision, and to analyze the reasons why the conduct was not performed.

Methods: we conducted a retrospective study with patients with pancreas tumors, evaluated between 2017 and 2019. Read More

View Article and Full-Text PDF
April 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap